Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-04-04 00:00:00 ET · period of report 2024-04-03 · accession 0001628280-24-014878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-04 | 2024-04-03 | VIR | De Backer Marianne | CEO, Dir | S - Sale | $9.46 | -73.0K | 678.5K | -10% | -$690.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-03 | S | D | 72,995 | $9.46 | 678,457 | D | — | — |